Early Prediction of Primary Non-Response to Infliximab in Crohn's Disease Using Routinely Available Clinical and Week 2 Laboratory Indicators: A Two-Center Real-World Cohort Study.
Zhao M et al. · 2026
NCBI PubMed Central · Papers · License: Open Access · 2026